AMW specializes in the development, manufacturing and distribution of parenteral drug delivery systems, such as passive and digitally controlled transdermal systems, as well as biodegradable sustained-release drug delivery systems for high potency peptides, proteins and small molecules. The focus is on increasing patient benefit and therapy adherence. In addition, AMW helps its partners with superior galenic development expertise to develop new products based on its technology platforms.

Licensing focuses on the indications of oncology, neurology, endocrinology, ophthalmology and pain management.

https://a-m-w.eu/